IP Library Granted Patent US 8,258,319
Granted Patent B2
US 8,258,319 · App. 13/168,029 · Granted Sep 4, 2012

Exo- and diastereo- selective synthesis of himbacine analogs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,258,319
App. No.
13/168,029
Granted
Sep 4, 2012
Kind
B2
Abstract

This application discloses a novel process for the preparation of himbacine analogs useful as thrombin receptor antagonists. The process is based in part on the use of a base-promoted dynamic epimerization of a chiral nitro center. The chemistry taught herein can be exemplified by the following:

Claims (20)

1. A process for preparing Compound 17:

said process comprising the steps of:

(a) cyclizing Compound 18 in a first solvent at an elevated temperature

wherein R 7 is selected from the group consisting of H, alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl, aryl, alkylaryl, arylalkyl, and heteroaryl groups

to produce a first mixture comprising α and β of the exo isomers of Compound 17A:

and α and β of the endo isomers of Compound 17B:

said isomers of Compound 17A having a trans-[5,6]-ring-junction;

(b) epimerizing said trans-[5,6]-ring-junction of Compound 17A by treating said first mixture with a first base to produce a second mixture comprising cis-[5,6]-ring-junction-nitro-α isomer and cis-[5,6]-ring-junction-nitro β isomer of each Compound 17C and Compound 17B:

and

(c) treating said second mixture with a second solvent, causing said α-isomer of Compound 17C to precipitate to produce Compound 17.

2. The process of claim 1 further comprising the step of treating said second mixture with a second base, resulting in a dynamic resolution of said second mixture, in which said β-isomer of Compound 17C is converted to α-isomer of Compound 17C, and α-isomer of Compound 17C is precipitated to produce Compound 17.

3. The process of claim 1 , wherein said first solvent is selected from the group consisting of xylene, N-methylpyrrolidinone, Dimethylsulfoxide, diphenyl ether, and Dimethylacetamide, and mixtures of 2 or more thereof.

4. The process of claim 1 , wherein said temperature is between about 70 and about 190° C.

5. The process of claim 1 , wherein said temperature is between about 80 and about 170° C.

6. The process of claim 1 , wherein said temperature is between about 100 and about 160° C.

7. The process of claim 1 , wherein said temperature is between about 120 and about 150° C.

8. The process of claim 1 , wherein said first base is selected from the group consisting of triethylamine; 1,5-diazabicyclo[4,3,0]non-5-ene 1,4-diazabicyclo[2,2,2]octane; and 1,8-diazabicyclo[5,4,0]undec-7-ene; and mixtures of 2 or more thereof.

9. The process of claim 1 , wherein said second solvent is selected from the group consisting of alcohols, ethers, ketones, esters, xylene, and N-methylpyrrolidinone, and mixtures of 2 or more thereof.

10. The process of claim 1 , wherein said second solvent is selected from the group consisting of methanol, ethanol, propanols, and butanols, xylene, N-methylpyrrolidinone, and mixtures of 2 or more thereof.

11. The process of claim 2 , wherein said second base is selected from the group consisting of triethylamine; 1,5-diazabicyclo[4,3,0]non-5-ene 1,4-diazabicyclo[2,2,2]octane; 1,8-diazabicyclo[5,4,0]undec-7-ene; and mixtures of 2 or more thereof.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2020
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: TOPROL ACQUISITION LLC
Reel/Frame 054027/0047 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2020
From: TOPROL ACQUISITION LLC
To: XSPIRE PHARMA, LLC
Reel/Frame 053731/0376 →
RECEIVING PARTY/ASSIGNEE ADDRESS CHANGE FOR ASSIGNMENT RECORDED AT REEL/FRAME 039767/0695 Recorded Aug 31, 2018
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 046989/0669 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY PREVIOUSLY RECORDED AT REEL: 046696 FRAME: 0772. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 30, 2018
From: ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046988/0741 →
SECURITY INTEREST Recorded Aug 24, 2018
From: ARALEZ PHARMACEUTICAL TRADING DAC
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046696/0772 →
SECURITY INTEREST Recorded Sep 29, 2016
From: ARALEZ PHARMACEUTICALS TRADING DAC
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PARTNERS, L.P.
Reel/Frame 039892/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: MERCK SHARP & DOHME CORP.
To: ARALEZ PHARMACEUTICALS TRADING DAC
Reel/Frame 039767/0695 →
CHANGE OF NAME Recorded Mar 11, 2013
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 029959/0019 →